Juno Therapeutics

12 Decision Makers · 14 Verified Contacts & Email Format

📍 Seattle, WABiotechnology🗓 Est. 2013👥 251–500 employees

About Juno Therapeutics

Juno Therapeutics is a clinical-stage company, develops immunotherapies for the treatment of cancer.

Email Format

{first_name}.{last_name}@junotherapeutics.com — 100.0%

sarah.smith@junotherapeutics.com

Leadership & Decision Makers

Contact details of 12 Juno Therapeutics decision makers

Lawrence Corey

Co-Founder

Hans Bishop

Co-Founder & CEO

Cynthia Elkins

EVP & CIO

Hyam Levitsky

Executive Vice President Research, Chief Scientific Officer

Isabelle Rivière

Scientific & Co-Founder

Michel Sadelain

Scientific Co-Founder

Steve Shamah

Head Of Scientific Operation

Bill Donahue

Senior Director, Head of Sequencing

Michael Jensen

Founder

Phil Greenberg

Founder

Renier Brentjens

Founder

Stan Riddell

Founder

Team & Specialists

Contact details of 2 Juno Therapeutics team members

Nikki Keith

  • Work email

    n*********h@junotherapeutics.com

James Sissons

  • Work email

    j***********s@junotherapeutics.com

General Emails

General company emails, e.g. customer support lines

    Info@junotherapeutics.com

    General Inquiries

    info@junotherapeutics.com

    General Inquiries

Similar Companies like Juno Therapeutics

Kite Pharma

kitepharma.com
Biotechnology · Los Angeles, CA · Est. 2009 · 101–250 employees

HQ: Los Angeles, CA

Adimab

adimab.com
Biotechnology · Lebanon, New Hampshire, United States · Est. 2007 · 101–250 employees

HQ: Lebanon, New Hampshire, United States

Seagen

seagen.com
Biotechnology · Bothell, Washington, United States · Est. 1998 · 1001–5000 employees · $500M–$1B

HQ: Bothell, Washington, United States

Biotechnology · Cheshire, Connecticut, United States · Est. 1992 · 1001–5000 employees

HQ: Cheshire, Connecticut, United States

Fulgent Therapeutics

fulgentgenetics.com
Biotechnology · Temple City, California, United States · Est. 2011 · 1001–5000 employees

HQ: Temple City, California, United States

Explore similar firms in the Biotechnology sector

Company Info

Last updated: 27/07/2025

+1 206-696-0703

Seattle, WA

Specialization: Clinical Trials, Oncology, Therapeutics
Legal Name: Juno Therapeutics, Inc.
Business Type: Delisted
Employees: 251-500
Rounds: Series B
Founded Date: 2013
Number of Exits: 2
Company Type: For Profit
Stock Symbol: NASDAQ:JUNO
Operating Status: Active
Last Funding Type: Series B
Phone Number: +1 206-696-0703
Last Investment Activity: Jun 21, 2023
Investments Activity: Jun 21, 2023 Apr 21, 2022 Jul 16, 2021

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.